Business Context and Reporting Period
Company: Astro-Med, Inc. (Note: Input metadata referenced "Astronova," but the filing text identifies the registrant as Astro-Med, Inc.)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: May 1, 2004 (First Quarter of Fiscal Year 2005)
Business Overview: A multi-national enterprise designing, manufacturing, and distributing data acquisition, storage, and analysis products. Operations are organized into three segments: Test & Measurement (T&M), QuickLabel Systems, and Grass-Telefactor (G-T).
Key Financial Metrics
| Metric | Q1 2004 | Q1 2003 |
|---|---|---|
| Net Sales | $14,242,268 | $13,214,120 |
| Gross Profit | $5,794,105 | $5,049,733 |
| Gross Margin | 40.7% | 38.2% |
| Operating Income | $935,500 | $487,380 |
| Net Income | $1,598,270 | $506,059 |
| Diluted EPS | $0.27 | $0.11 |
| Cash & Equivalents | $3,805,354 | $2,828,059 |
| Total Current Assets | $35,713,937 | $32,017,111 |
| Total Current Liabilities | $7,160,670 | $7,517,828 |
| Operating Cash Flow | ($383,038) | $783,072 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 7.8% year-over-year, driven by double-digit growth in the T&M (+51.6%) and QuickLabel (+15.3%) segments. The G-T segment declined 16.9% due to cyclical Long-term Epilepsy Monitoring (LTM) sales.
- Profitability Surge: Net income more than tripled to $1.60 million. This was significantly boosted by a one-time non-cash income tax benefit of $939,000 resulting from the release of a valuation allowance on deferred tax assets.
- Margin Expansion: Gross margin improved to 40.7% from 38.2%, attributed to favorable sales mix and better manufacturing overhead absorption.
- Cash Flow Deterioration: Operating cash flow turned negative ($383k outflow) compared to a $783k inflow in the prior year. This was primarily due to the payment of fiscal 2004 bonuses/commissions and a slowdown in the cash collection cycle (60 days vs. 57 days).
- Dividends: The company declared a 10% stock dividend (distributed May 26, 2004) and paid a cash dividend of $0.04 per share.
Outlook, Risks, and Management Commentary
- Segment Performance: Management highlighted strong demand for the Everest Telemetry Workstation and Dash 8x Portable Data Recorder in the T&M segment. QuickLabel growth was driven by the 4100Xe and 8100Xe color printer systems. G-T weakness is attributed to lower research instrumentation sales.
- Liquidity: The company maintains $12.0 million in cash and securities available for sale. It has a $3.5 million unsecured bank line of credit, all of which is currently available.
- Capital Expenditures: $499,000 was spent on machinery and equipment to increase capacity and efficiency.
- Risks: Forward-looking statements cite risks including declining demand in defense/aerospace markets, competition in specialty printers and neurophysiology, foreign currency exchange rate impacts, and the ability to integrate acquisitions.
- Accounting Policy Change: Management determined that an appropriate level of profitability has been sustained, allowing for the realization of deferred tax assets previously reserved against.
Investor Verification Checklist
- Tax Benefit Sustainability: Verify the sustainability of the $939,000 one-time tax benefit; future earnings will not include this non-recurring item.
- Cash Conversion Cycle: Monitor the slowing cash collection cycle (60 days) and its impact on working capital needs.
- G-T Segment Recovery: Assess the cyclical nature of the Grass-Telefactor decline and the timeline for recovery in LTM sales.
- Stock Dividend Impact: Confirm the restatement of historical EPS and share counts due to the 10% stock dividend.
- Debt Capacity: Note the full availability of the $3.5 million credit line as a liquidity buffer.